Reconnecting Intent & Action
At Epia Neuro™ we build products that learn the brain’s intent and carry it out in the physical world, giving people back their independence.
The Unmet Need
For millions of people with disabilities, the body no longer does what the mind intends.
Stroke is a leading cause of serious long-term disability. For many stroke survivors, the pathway from intent to movement is damaged.
Designed with and for stroke survivors, our solution aims at restoring skilled, context-aware action: a thought drives intent, a world model perceives the scene, a policy selects the movement, and a controller carries it out through our grip-assist exo.
Introducing Our System
A solution at the frontier
of technology.
Epia’s first product is built to restore hand function after stroke.
.png)
Intelligence
Adaptive models that understand the scene and the objects in it turn intent into the right movement. They keep learning, getting better at both understanding intent and carrying it out.
Brain Interface
A proprietary implant learns intent from the brain, and how each person expresses it. Nothing penetrates the brain or the membrane that protects it.
Hand Exoskeleton
A lightweight, affordable soft robotics glove carries out the action, restoring the ability to grasp objects, release them, and perform the tasks of everyday life. Shaped by close collaboration with stroke survivors, advocates, and clinicians.
Brain Interface
A proprietary implant learns intent from the brain, and how each person expresses it. Nothing penetrates the brain or the membrane that protects it.
Intelligence
Adaptive models that understand the scene and the objects in it turn intent into the right movement. They keep learning, getting better at both understanding intent and carrying it out.
Hand Exoskeleton
A lightweight, affordable soft robotics glove carries out the action, restoring the ability to grasp objects, release them, and perform the tasks of everyday life. Shaped by close collaboration with stroke survivors, advocates, and clinicians.
Designed For Everyday Life
Everything we design is intended for years of everyday use.
We want our products to be accessible to anyone who needs them.
Clinically Scalable
Placed in under an hour with standard neurosurgical tools, the implant sits in the skull under the skin, without piercing the dura that protects the brain.
Rechargeable
Recharged wirelessly through a comfortable headset.
Future-Proof
The implant is designed to be swapped for newer versions in a short, simple procedure, so people can benefit from future upgrades.
Stroke therapy proves the platform. The platform treats across Neurology.
Cognitive Decline
Continuous recording from the brain, paired with a model that learns what a person is trying to do, extending assistance from movement to everyday tasks.
Movement Disorders
Adaptive stimulation driven by real-time feedback, replacing fixed-parameter programming.
Our Team
Michel Maharbiz, Ph.D.
Chief Executive Officer
Serial entrepreneur, Founder of iota Biosciences, and former professor of Electrical Engineering and Computer Science (EECS), Bioengineering and the Helen Wills Neuroscience Institute (HWNI) at the University of California, Berkeley
Gil Mandelbaum, Ph.D.
Chief Technology & Science Officer
Neuroscientist and technology leader with more than 15 years of experience developing hardware and software systems for neuroscience research and clinical applications
Michelle Patruno
Chief Operating Officer
Operations executive with more than 15 years of experience scaling high-growth organizations and building teams and systems to support sustainable growth from early stage through IPO
Our Advisors
Dr. David J. Lin, MD
Director, NeuroRecovery Clinic, Massachusetts General Hospital, Boston
Dr. Lin is a critical care neurologist, neurorehabilitation specialist, and Director of the NeuroRecovery Clinic and Laboratory for Translational Recovery at Massachusetts General Hospital (MGH). He specializes in the care of patients with stroke, traumatic brain injury, and spinal cord injury across the acute to post-acute care continuum. His research program focuses on neurologic mechanisms of motor recovery after stroke.
Prof. Bernardo Sabatini, MD, PhD
Professor of Neurobiology & HHMI Investigator; Co-Director, Kempner Institute for the Study of Natural and Artificial Intelligence, Harvard University
Dr. Sabatini is a Howard Hughes Medical Institute Investigator at Harvard Medical School whose laboratory pioneered optical and chemical tools to study synaptic signaling and its role in neuropsychiatric disease. As Co-Director of the Kempner Institute, he leads research at the intersection of neuroscience and AI, using insights from neural circuits to advance machine learning architectures. He is a member of the National Academy of Sciences and the American Academy of Arts and Sciences.
Dr. Mark Richardson, MD, PhD
Director, Functional Neurosurgery, Massachusetts General Hospital, Boston
Dr. Richardson is a neurosurgeon and neuroscientist recognized internationally for his work in epilepsy surgery, deep brain stimulation, and experimental gene and cell therapy. He founded the Brain Modulation Lab, a human systems neuroscience lab centered on intracranial electrophysiology, is co-founder of the MGH-MIT InBRAIN Collaboration, and has served on the Executive Board of the American Society for Stereotactic and Functional Neurosurgery.
Dr. Netanel Ben-Shalom, MD, FNPS
Director, Neuroplastic & Reconstructive Surgery Program, Lenox Hill Hospital, NYC
Dr. Ben-Shalom is internationally recognized as the world's first neurosurgeon to complete the Johns Hopkins Neuroplastic and Reconstructive Surgery fellowship. His dual expertise in neurosurgical oncology and neuroplastic surgery enables a patient-centered approach utilizing 3D printing and third-generation cranial implants. He is co-founder of New York's first Neuroplastic and Reconstructive Surgery Program.
Prof. Jan M. Rabaey
Donald O. Pederson Distinguished Professor Emeritus, EECS, University of California, Berkeley
Prof. Rabaey is a Professor at UC Berkeley and co-founder of the Berkeley Wireless Research Center. He also serves as CTO of IMEC’s System-Technology Co-Optimization division. His contributions span low-power integrated circuits, advanced wireless systems, sensor networks, and brain-computer interfaces, including the Human Intranet. He is an IEEE Life Fellow and a member of the Royal Flemish Academy of Arts and Sciences.
Marc W Slutzky, MD, PhD
Professor of Neurology, Neuroscience & Biomedical Engineering Northwestern University Feinberg School of Medicine
Dr. Slutzky is a Northwestern-trained neurologist and neural engineer, serving as Professor of Neurology and Neuroscience at Northwestern University, where he also practices as a treating neurologist. Specializing in brain-machine interfaces to restore movement and communication in patients with paralysis, stroke, and ALS, he is widely recognized as an international leader in translational neural engineering and serves as President of the Brain Computer Interface Society.
Dr. Joshua Aronson, MD
Director of Epilepsy Surgery, Beth Israel Deaconess Medical Center, Boston
Dr. Aronson is a Harvard-trained internationally recognized neurosurgeon specializing in deep brain stimulation, minimally invasive epilepsy surgery, and facial pain treatment. He has built multiple pioneering surgical programs across leading institutions including Massachusetts General Hospital and Dartmouth-Hitchcock Medical Center, and is a widely respected leader in academic neurosurgery.
Rebuilding the connection between brain and body.
If you want your work to restore independence for millions of people, we want to hear from you.
.png)
Epia Neuro™ is committed to advancing transparent dialogue around the future of brain computer interfaces and neuromodulation.
For Press Inquiries